Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-15

Clinical Trial Update: Comparison of the Oxymask and Oxy2mask on Supplemental Oxygen Delivery [NA]

View source ↗

Summary

A clinical trial comparing Oxymask and Oxy2mask for supplemental oxygen delivery in hypoxia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxy2mask
  • Oxymask

Snippet

Sponsor: Northwestern Medicine | Conditions: Hypoxia | NA | Status: WITHDRAWN